Utama › Kanser (semua jenis) › Ohio › Columbus
Kajian klinikal Kanser (semua jenis) di Columbus, OH
38 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Mengambil pesertaFasa 1/2
- GSK Investigational Site, Columbus
Met Non Small Cell Cancer Registry (MOMENT)
Mengambil pesertaKajian pemerhatian
- The Ohio State University Wexner Medical Center, Columbus
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Mengambil pesertaFasa 3
- The Ohio State University, Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Mengambil pesertaFasa 2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 8, Columbus
Pan Tumor Rollover Study
Mengambil pesertaFasa 2
- The Ohio University, Columbus
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Collection of Tissue Samples for Cancer Research
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Mengambil pesertaFasa 2
- The Ohio State University, Department of Psychiatry, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Mengambil pesertaFasa 2
- Nationwide Children's Hosp, Columbus
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- dan 8 lagi
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Mengambil pesertaFasa 2
- Nationwide Children's Hospital, Columbus
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Mengambil peserta
- Nationwide Children's Hospital, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Mengambil pesertaFasa 1/2
- The Ohio State University /ID# 271336, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Mengambil pesertaFasa 1
- The Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Childhood Cancer Survivor Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Nationwide Children's Hospital, Columbus
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Mengambil pesertaFasa 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Mengambil pesertaFasa 1/2
- The Ohio State University Wexner Medical Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Mengambil pesertaKajian pemerhatian
- Ohio State University Wexner Medical Center, Columbus
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Mengambil peserta
- Nationwide Children's Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Mengambil pesertaFasa 2
- The Ohio State University /ID# 230439, Columbus
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
- OhioHealth Reseach Institute, Columbus
Preparing for Life and Academics for Young Childhood Cancer Survivors
Mengambil peserta
- Nationwide Children's Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Mengambil pesertaKajian pemerhatian
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Mengambil peserta
- Ohio State University Comprehensive Cancer Center, Columbus
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
Kajian lain di Columbus
- Kanser Paru-paru Bukan Sel Kecil56 kajian
- Kanser Payudara39 kajian
- Kanser Ovari39 kajian
- Kanser Paru-paru37 kajian
- Leukemia Mieloid Akut35 kajian
- Leukemia Limfositik Kronik28 kajian
- Kanser Metastatik27 kajian
- Kanser Endometrium25 kajian
- Kanser Kolorektal24 kajian
- Kanser Prostat24 kajian
- Mieloma Pelbagai24 kajian
- Melanoma21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.